UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. POEMS症候群 poems syndrome
2. キャッスルマン病 castlemans disease
3. 多発性骨髄腫の臨床的特徴、検査所見、および診断 clinical features laboratory manifestations and diagnosis of multiple myeloma
4. エルドハイム・チェスター病 erdheim chester disease
5. 末梢神経と筋肉に影響を与える腫瘍随伴性症候群 paraneoplastic syndromes affecting peripheral nerve and muscle

Japanese Journal

クロウ・深瀬症候群(POEMS症候群) (特集続・日本人の発見した神経疾患)

岩下宏
Brain and nerve 63(2), 131-139, 2011-02
NAID 40018721583

医療技術自助具を利用した家事動作訓練により単身生活が可能となったクロウ・深瀬症候群の一例

石川哲也,笹田哲,須山夏加 [他]
共済医報 58(3), 200-203, 2009-08
NAID 40016832432

Related Pictures

★リンクテーブル★

リンク元	「ポエムス症候群」「骨硬化性骨髄腫」「Crow-Fukase syndrome」「Crow-Fukase症候群」「Crow・深瀬症候群」
関連記事	「症候群」「群」「症候」「ロウ」

「ポエムス症候群」

　　[★]

英: POEMS syndrome
同: クロウ・深瀬症候群 Crow-Fukase症候群 Crow-Fukase syndrome、高月病 Takatsuki disease

[show details]

ポエムス症候群 : 46 件
ポエムズ症候群 : 15 件
POEMS症候群 : 約 13,700 件
クロウ・深瀬症候群 : 89 件

en

Crow-Fukase syndrome : 約 29,300 件
POEMS syndrome : 約 334,000 件

ja

Crow-Fukase syndrome : 約 1,710 件
POEMS syndrome : 約 3,640 件

参考

1. 単クローン抗体を伴う末梢神経炎（クロウ・フカセ症候群、POEMS症候群） - 難病情報センター

http://www.nanbyou.or.jp/entry/241

2．[PDF]診断基準など

http://www.celltherapytransplantation.com/520-3_520.pdf

3. 疫学研究としての診断基準

http://www.m.chiba-u.ac.jp/class/neurol/kenkyu/ishisyudou/crow-fukase/ishi/sindan.html

腎障害を伴うPOEMS症候群

検索ワード「POEMS syndrome glomerulonephritis」

Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure.

http://www.ncbi.nlm.nih.gov/pubmed/21979795

Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation.

http://www.ncbi.nlm.nih.gov/pubmed/16564945

Although not included in the acronym, renal lesions also are characteristic of this disease and sometimes require dialysis therapy.

腎障害も良く合併するんだって

POEMS syndrome: definitions and long-term outcome.

http://www.ncbi.nlm.nih.gov/pubmed/12456500

The POEMS syndrome (coined to refer to polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) remains poorly understood. Ambiguity exists over the features necessary to establish the diagnosis, treatment efficacy, and prognosis. We identified 99 patients with POEMS syndrome. Minimal criteria were a sensorimotor peripheral neuropathy and evidence of a monoclonal plasmaproliferative disorder. To distinguish POEMS from neuropathy associated with monoclonal gammopathy of undetermined significance, additional criteria were included: a bone lesion, Castleman disease, organomegaly (or lymphadenopathy), endocrinopathy, edema (peripheral edema, ascites, or effusions), and skin changes.

Successful stabilisation of nephropathy in a patient with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-band, skin changes) syndrome on treatment with mycophenolate and steroids: a case report

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848064/

Nakamoto et al. [7] reviewed 52 cases of Japanese patients with nephropathy. All patients manifested four or all of the five signs of POEMS. Polyneuropathy was present in all but one patient. A majority of cases had monoclonal protein in blood (either IgA- or IgG-) although 10 demonstrated a polyclonal hypergammaglobulinaemia, but in these, four other signs of POEMS supported the diagnosis.

Nakamoto et al. [7] -> http://www.ncbi.nlm.nih.gov/pubmed/10528660